(Q28146148)

GOA release 2020-03-11

1 reference

E Arikawa-Hirasawa

1

0 references

H Watanabe

2

0 references

H Takami

3

0 references

J R Hassell

4

0 references

Y Yamada

The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices

5

0 references

language of work or name

English

0 references

publication date

November 1999

0 references

published in

Nature Genetics

0 references

volume

23

0 references

page(s)

354-8

0 references

issue

3

0 references

cites work

1 reference

7 January 2021

Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis

1 reference

7 January 2021

Developmental expression of perlecan during murine embryogenesis

1 reference

7 January 2021

Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.

1 reference

7 January 2021

Fibroblast growth factor receptor 3 and the human chondrodysplasias.

1 reference

7 January 2021

A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors

1 reference

7 January 2021

Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia

1 reference

7 January 2021

Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia

1 reference

7 January 2021

Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein

1 reference

7 January 2021

Mouse models for extracellular matrix diseases.

1 reference

7 January 2021

Mice lacking link protein develop dwarfism and craniofacial abnormalities.

1 reference

7 January 2021

Fibroblast growth factor receptor 3 is a negative regulator of bone growth

1 reference

7 January 2021

The role of mesenchyme-like tissue in the pathogenesis of thanatophoric dysplasia

1 reference

7 January 2021

Abnormal ossification in thanatophoric dysplasia

1 reference

7 January 2021

Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein

1 reference

7 January 2021

Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.

1 reference

7 January 2021

Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism

1 reference

7 January 2021

FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway

1 reference

7 January 2021

FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.

1 reference

7 January 2021

Abnormal FGFR 3 expression in cartilage of thanatophoric dysplasia fetuses

1 reference

7 January 2021

Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA

1 reference

7 January 2021

Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene

1 reference

7 January 2021

Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide

1 reference

7 January 2021

Genetic landmarks for defects in mouse neural tube closure

1 reference

7 January 2021